Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| 1 |
Apple
AAPL
|
$619M |
| 2 |
Microsoft
MSFT
|
$486M |
| 3 |
Broadcom
AVGO
|
$479M |
| 4 |
Cisco
CSCO
|
$238M |
| 5 |
Meta Platforms (Facebook)
META
|
$235M |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
$450M |
| 2 |
VMW
VMware, Inc
VMW
|
$293M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$189M |
| 4 |
SPLK
Splunk Inc
SPLK
|
$168M |
| 5 |
Danaher
DHR
|
$135M |
Sector Composition
| 1 | Technology | 29.63% |
| 2 | Healthcare | 12.35% |
| 3 | Financials | 12.25% |
| 4 | Consumer Discretionary | 9.98% |
| 5 | Industrials | 7.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2826
UroGen Pharma
URGN
$873M
| $43K | ﹤0.01% |
2,868
+738
| +35% | +$11.1K |
|
2827
ReNew
RNW
$2.83B
| $42.4K | ﹤0.01% |
5,533
-5,144
| -48% | -$39.4K |
|
2828
Bowman Consulting
BWMN
$704M
| $42.2K | ﹤0.01% |
1,189
+61
| +5% | +$2.17K |
|
|
ONL
2829
Orion Office REIT
ONL
$170M
| $42.1K | ﹤0.01% |
7,368
-22,703
| -75% | -$130K |
|
|
VNET
2830
VNET Group
VNET
$2.13B
| $41.6K | ﹤0.01% |
14,491
| – | – |
|
2831
Miller Industries
MLR
$479M
| $41.6K | ﹤0.01% |
983
| – | – |
|
2832
GCM Grosvenor
GCMG
$680M
| $41.1K | ﹤0.01% |
4,582
-14,993
| -77% | -$134K |
|
2833
First Foundation Inc
FFWM
$502M
| $40.7K | ﹤0.01% |
4,204
-62,529
| -94% | -$605K |
|
2834
Outset Medical
OM
$249M
| $40.7K | ﹤0.01% |
501
-2,248
| -82% | -$183K |
|
2835
ASE Group
ASX
$22.8B
| $40.7K | ﹤0.01% |
4,323
| – | – |
|
2836
Maplebear
CART
$11.9B
| $40K | ﹤0.01% |
1,707
-793
| -32% | -$18.6K |
|
2837
Caribou Biosciences
CRBU
$174M
| $39.8K | ﹤0.01% |
6,941
+747
| +12% | +$4.28K |
|
2838
AngioDynamics
ANGO
$436M
| $39.7K | ﹤0.01% |
5,065
-26,835
| -84% | -$210K |
|
2839
SoundThinking
SSTI
$157M
| $39.4K | ﹤0.01% |
1,543
-3,183
| -67% | -$81.3K |
|
2840
Telkom Indonesia
TLK
$19.2B
| $39.2K | ﹤0.01% |
1,520
| – | – |
|
2841
Viemed Healthcare
VMD
$267M
| $39K | ﹤0.01% |
5,010
| – | – |
|
2842
Avita Medical
RCEL
$115M
| $38.5K | ﹤0.01% |
2,805
-85
| -3% | -$1.17K |
|
2843
Prime Medicine
PRME
$663M
| $38.4K | ﹤0.01% |
4,336
-188
| -4% | -$1.67K |
|
2844
CNB Financial Corp
CCNE
$768M
| $38.2K | ﹤0.01% |
1,689
| – | – |
|
2845
Ocular Therapeutix
OCUL
$2.37B
| $37.8K | ﹤0.01% |
8,473
-436
| -5% | -$1.95K |
|
|
JBIO
2846
Jade Biosciences, Inc. Common Stock
JBIO
$254M
| $37.7K | ﹤0.01% |
48
-172
| -78% | -$135K |
|
|
DSKE
2847
DELISTED
Daseke, Inc. Common Stock
DSKE
| $37.7K | ﹤0.01% |
4,653
| – | – |
|
2848
CVRx
CVRX
$204M
| $37.7K | ﹤0.01% |
1,198
-114
| -9% | -$3.58K |
|
2849
Vanda Pharmaceuticals
VNDA
$272M
| $37.5K | ﹤0.01% |
8,897
-35,001
| -80% | -$148K |
|
2850
Limbach Holdings
LMB
$1.25B
| $37.2K | ﹤0.01% |
819
+61
| +8% | +$2.77K |
|